13F-HR filed by RA CAPITAL MANAGEMENT, L.P.
RA CAPITAL MANAGEMENT, L.P. filed this 13F-HR for the quarter ended 2020-12-31, filed 2021-02-16, with 82 holding rows worth $7,153,595,000.
- Accession
- 0001104659-21-024161
- Filer
- CIK 1346824
- Filed
- 2021-02-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2020
A holdings report, 82 entries on the cover page, a total value of $7,153,595,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $7,153,595,000 with VALUE read as thousands by filing date, 13F file number 028-12884. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 5,865,338 | $978,221,000 | thousands by filing date | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 8,685,471 | $451,818,000 | thousands by filing date | |
| NOVAVAX INC | 670002401 | COM NEW | 3,788,564 | $422,463,000 | thousands by filing date | |
| NKARTA INC | 65487U108 | COMMON STOCK | 5,605,129 | $344,547,000 | thousands by filing date | |
| FORMA THERAPEUTICS HLDGS INC | 34633R104 | SHS | 9,011,651 | $314,507,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 3,672,872 | $311,937,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 4,776,548 | $295,764,000 | thousands by filing date | |
| ATEA PHARMACEUTICALS INC | 04683R106 | COMMON STOCK | 5,368,451 | $224,294,000 | thousands by filing date | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 4,417,258 | $149,392,000 | thousands by filing date | |
| KINNATE BIOPHARMA INC | 49705R105 | COM | 3,593,052 | $142,932,000 | thousands by filing date | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 1,655,447 | $134,869,000 | thousands by filing date | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 1,875,000 | $132,263,000 | thousands by filing date | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 3,825,008 | $127,067,000 | thousands by filing date | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 4,179,067 | $124,244,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 4,557,867 | $124,225,000 | thousands by filing date | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 18,417,458 | $118,793,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 2,136,081 | $117,143,000 | thousands by filing date | |
| 89BIO INC | 282559103 | COM | 4,736,214 | $115,422,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 5,345,631 | $106,859,000 | thousands by filing date | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 1,710,265 | $105,198,000 | thousands by filing date | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 2,150,404 | $103,391,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 9,502,383 | $103,006,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 4,375,217 | $100,017,000 | thousands by filing date | |
| VAXCYTE INC COM | 92243G108 | Stock | 3,710,699 | $98,593,000 | thousands by filing date | |
| IGM BIOSCIENCES INC | 449585108 | COM | 982,723 | $86,765,000 | thousands by filing date | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 2,589,904 | $83,006,000 | thousands by filing date | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 1,742,186 | $80,733,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 5,290,481 | $77,823,000 | thousands by filing date | |
| SOLID BIOSCIENCES INC COM NEW | 83422E105 | Stock | 9,976,569 | $75,622,000 | thousands by filing date | |
| KALA BIO INC COM | 483119103 | Stock | 10,874,613 | $73,730,000 | thousands by filing date | |
| FIVE PRIME THERAPEUTICS INC. | 33830X104 | Common Stock | 4,285,161 | $72,891,000 | thousands by filing date | |
| INHIBRX INC | 45720L107 | COM | 2,129,003 | $70,193,000 | thousands by filing date | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 2,408,292 | $67,818,000 | thousands by filing date | |
| CURIS INC | 231269200 | COM | 7,707,790 | $63,127,000 | thousands by filing date | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 7,775,207 | $61,191,000 | thousands by filing date | |
| CARDIFF ONCOLOGY INC | 14147L108 | COM | 3,290,000 | $59,187,000 | thousands by filing date | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 2,805,045 | $58,906,000 | thousands by filing date | |
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 1,852,746 | $53,359,000 | thousands by filing date | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 1,987,997 | $51,569,000 | thousands by filing date | |
| GERON CORP | 374163103 | COM | 30,126,299 | $47,901,000 | thousands by filing date | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 2,118,212 | $45,986,000 | thousands by filing date | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 1,377,569 | $45,639,000 | thousands by filing date | |
| AKOUOS INC | 00973J101 | COM | 2,281,249 | $45,237,000 | thousands by filing date | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 1,000,000 | $41,560,000 | thousands by filing date | |
| INOZYME PHARMA INC | 45790W108 | COM | 2,003,653 | $41,355,000 | thousands by filing date | |
| ORCHARD THERAPEUTICS PLC | 68570P101 | ADR | 12,315,213 | $41,155,000 | thousands by filing date | |
| ARDELYX INC | 039697107 | COM | 6,163,086 | $39,875,000 | thousands by filing date | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 2,200,000 | $36,476,000 | thousands by filing date | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 1,165,184 | $32,777,000 | thousands by filing date | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 1,515,151 | $32,439,000 | thousands by filing date | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 5,100,000 | $31,824,000 | thousands by filing date | |
| PANDION THERAPEUTICS INC | 698340106 | COM | 1,770,023 | $26,285,000 | thousands by filing date | |
| ALECTOR INC | 014442107 | COMMON STOCK | 1,616,879 | $24,463,000 | thousands by filing date | |
| CONCERT PHARMACEUTICALS INC | 206022105 | COM | 1,823,520 | $23,049,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 1,023,067 | $22,753,000 | thousands by filing date | |
| SATSUMA PHARMACEUTICALS INC | 80405P107 | COM | 4,681,858 | $21,583,000 | thousands by filing date | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 584,000 | $19,768,000 | thousands by filing date | |
| SCPHARMACEUTICALS INC | 810648105 | COM | 3,518,998 | $18,615,000 | thousands by filing date | |
| MARINUS PHARMACEUTICALS INC | 56854Q200 | COM NEW | 1,300,000 | $15,860,000 | thousands by filing date | |
| VAXART INC NEW | 92243A200 | COM | 2,742,271 | $15,658,000 | thousands by filing date | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 2,327,714 | $15,596,000 | thousands by filing date | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 750,000 | $15,525,000 | thousands by filing date | |
| BCTG ACQUISITION CORP | 05492W103 | COM | 1,250,000 | $14,300,000 | thousands by filing date | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 409,000 | $14,029,000 | thousands by filing date | |
| BCLS ACQUISITION CORP | G0904B105 | CMN | 1,250,000 | $13,925,000 | thousands by filing date | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 2,499,025 | $13,470,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 1,025,641 | $11,518,000 | thousands by filing date | |
| ARYA SCIENCES ACQUISITION CO | G3166W106 | COM CL A | 1,000,000 | $10,850,000 | thousands by filing date | |
| FRAZIER LIFESCIENCES ACQU CORP UNIT EXP 120925 | G3710A121 | Stock | 1,000,000 | $10,380,000 | thousands by filing date | |
| THERAPEUTICSMD INC | 88338N107 | COM | 7,812,500 | $9,453,000 | thousands by filing date | |
| LYRA THERAPEUTICS INC | 55234L105 | COM | 815,849 | $9,301,000 | thousands by filing date | |
| PASSAGE BIO INC | 702712100 | COM | 322,630 | $8,250,000 | thousands by filing date | |
| HEALTH SCIENCES ACQ CORP 2 | G4411D109 | ORD SHS | 625,000 | $8,006,000 | thousands by filing date | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 564,102 | $7,959,000 | thousands by filing date | |
| MOONLAKE IMMUNOTHERAPEUTICS | G4444C102 | COM | 700,000 | $7,959,000 | thousands by filing date | |
| 5 01 ACQUISITION CORP | 33836P105 | CMN | 750,000 | $7,628,000 | thousands by filing date | |
| MIRAGEN THERAPEUTICS INC | 60463E202 | COM NEW | 451,932 | $7,434,000 | thousands by filing date | |
| IMARA INC | 45249V107 | COM | 248,804 | $5,486,000 | thousands by filing date | |
| PROFOUND MED CORP | 74319B502 | COM NEW | 192,311 | $3,954,000 | thousands by filing date | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 536,962 | $3,453,000 | thousands by filing date | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U102 | *W EXP 06/09/202 | 233,333 | $1,318,000 | thousands by filing date | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 285,000 | $658,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-21-024161 | this filing | 2021-02-16 | acceptance time not in the bulk data set |